The Medicaid hospital provider tax reforms in Republicans’ 2025 reconciliation law could lower employer-sponsored insurance premiums by 2.2% compared with what they otherwise would have been, ...

The Trump administration is withholding more Medicaid funding from California due to alleged fraud, following an initial deferral earlier this year that sparked alarm from home care providers in the ...

The brand drug lobby and at least three drug companies are asking a district court in Maine for permission to intervene on the side of the government in a recent hospital lawsuit against HHS’ upcoming ...

Improving bioequivalence testing for complex drugs and drug-device combinations, developing new approaches to address impurities in generics and expanding the use of artificial intelligence in ...

The administration said Friday (Oct. 16) it completed a review of recertification applications from five of the existing Independent Dispute Resolution (IDR) entities and determined that they meet ...

HHS Tuesday (Oct. 20) unveiled a national kidney care plan focused on disease prevention, improving dialysis care and strengthening the transplant system.

The Trump administration must continue providing transition care to prison inmates with gender dysphoria, says an unsigned order the Supreme Court issued Wednesday (Oct. 21), as a case over President ...

CMS is considering reducing the traditional role of Unified Program Integrity Contractors so it can take direct control over which providers and suppliers become targets of Medicare fraud ...

Key Senate Democrats have no confidence that technology companies' Medicaid eligibility systems will be error-free by the Jan. 1 start date for work requirements, and the senators' interim final ...

National Institutes of Health Director Jay Bhattacharya is inviting prospective participants in a new vaccine injury clinic to contact the agency as it finalizes protocol ahead of its upcoming launch, ...

Seniors are estimated to spend significantly more out-of-pocket annually on certain oncology and immunotherapy drugs under the “One Big Beautiful Bill” Act provision blocking all types of orphan drugs ...

As HHS advances initiatives using artificial intelligence to modernize clinical trials, rare disease advocates are mostly hopeful the promise of faster trials with fewer participants indicates ...